# Donald E. Cutlip

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/donald-e-cutlip/

## Facts

| Field | Value |
| --- | --- |
| Citations | 57,295 |
| Field | Coronary Interventions and Diagnostics |
| h-index | 89 |
| i10-index | 234 |
| Last Known Institution | Beth Israel Deaconess Medical Center |
| OpenAlex ID | https://openalex.org/A5057352435 |
| ORCID iD | https://orcid.org/0000-0002-7583-9893 |
| Works | 387 |

## Researcher papers

Showing 12 of 22.

- [Clinical End Points in Coronary Stent Trials](https://scholariq.org/papers/clinical-end-points-in-coronary-stent-trials/)
- [Standardized Bleeding Definitions for Cardiovascular Clinical Trials](https://scholariq.org/papers/standardized-bleeding-definitions-for-cardiovascular-clinical-trials/)
- [Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis](https://scholariq.org/papers/stenting-versus-endarterectomy-for-treatment-of-carotid-artery-stenosis/)
- [Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients](https://scholariq.org/papers/protected-carotid-artery-stenting-versus-endarterectomy-in-high-risk-patients/)
- [Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents](https://scholariq.org/papers/twelve-or-30-months-of-dual-antiplatelet-therapy-after-drug-eluting-stents/)
- [A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting](https://scholariq.org/papers/a-clinical-trial-comparing-three-antithrombotic-drug-regimens-after-coronary/)
- [Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium](https://scholariq.org/papers/standardized-endpoint-definitions-for-transcatheter-aortic-valve-implantation/)
- [Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document](https://scholariq.org/papers/standardized-end-point-definitions-for-coronary-intervention-trials-the-academic/)
- [Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention](https://scholariq.org/papers/development-and-validation-of-a-prediction-rule-for-benefit-and-harm-of-dual/)
- [Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention](https://scholariq.org/papers/defining-high-bleeding-risk-in-patients-undergoing-percutaneous-coronary-2/)
- [Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials](https://scholariq.org/papers/standardized-endpoint-definitions-for-transcatheter-aortic-valve-implantation-2/)
- [2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials](https://scholariq.org/papers/2017-cardiovascular-and-stroke-endpoint-definitions-for-clinical-trials/)

## Researcher topics

- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)

## Researcher university

- [Beth Israel Deaconess Medical Center](https://scholariq.org/institutions/beth-israel-deaconess-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.